Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Xenical won by Y&R's Media Marketing

Published on .

Hoffmann-La Roche awarded general media-buying duties for fat-fighting drug Xenical to Media Marketing Solutions, New York, which also retained influenza drug Tamiflu, according to Loretta Volpe, president-CEO of the shop. Combined, the accounts are estimated at $50 million. Media Marketing is a small agency owned by Young & Rubicam that handles accounts that its Media Edge unit cannot. Lowe Lintas & Partners Worldwide, New York, handled media for Xenical's launch.

Copyright October 2000, Crain Communications Inc.

Most Popular
In this article: